Aligos Therapeutics(ALGS) - 2024 Q2 - Quarterly Results

EXHIBIT 99.1 Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results SOUTH SAN FRANCISCO, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, "Aligos"), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today reported recent business progress and financial results for the second quarter 2024. "This quarter we continued to execute on our key clini ...